Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Worcester

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of the American Society of Nephrology : JASN|November 1, 1994
Urinary calcium oxalate crystal growth inhibitorsE M Worcester
Seminars in Nephrology|September 1, 1996
Inhibitors of stone formationE M Worcester
Annals of the New York Academy of Sciences|April 21, 1995
Osteopontin inhibits nucleation of calcium oxalate crystalsE M Worcester, A M Beshensky
Mineral and Electrolyte Metabolism|January 1, 1987
Glycoprotein calcium oxalate crystal growth inhibitor in urineE M Worcester, Y Nakagawa, F L Coe
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1991
Hypercalciuria and stonesJ Lemann, E M Worcester, R W Gray
The Journal of Urology|March 29, 2000
Role of anionic proteins in kidney stone formation: interaction between model anionic polypeptides and calcium oxalate crystalsJ A Wesson, E M Worcester, J G Kleinman
Annals of the New York Academy of Sciences|April 21, 1995
Osteopontin production by cultured kidney cellsE M Worcester, J G Kleinman, A M Beshensky
Kidney International|June 1, 1995
Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidneyJ G Kleinman, A Beshensky, E M Worcester, et al.
Nephron|January 1, 1994
Effect of renal transplantation on serum oxalate and urinary oxalate excretionE M Worcester, S K Fellner, Y Nakagawa, et al.
The Journal of Clinical Investigation|June 1, 1986
Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failureE M Worcester, Y Nakagawa, D A Bushinsky, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of the American Society of Nephrology : JASN|November 1, 1994
Urinary calcium oxalate crystal growth inhibitorsE M Worcester
Seminars in Nephrology|September 1, 1996
Inhibitors of stone formationE M Worcester
Annals of the New York Academy of Sciences|April 21, 1995
Osteopontin inhibits nucleation of calcium oxalate crystalsE M Worcester, A M Beshensky
Mineral and Electrolyte Metabolism|January 1, 1987
Glycoprotein calcium oxalate crystal growth inhibitor in urineE M Worcester, Y Nakagawa, F L Coe
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1991
Hypercalciuria and stonesJ Lemann, E M Worcester, R W Gray
The Journal of Urology|March 29, 2000
Role of anionic proteins in kidney stone formation: interaction between model anionic polypeptides and calcium oxalate crystalsJ A Wesson, E M Worcester, J G Kleinman
Annals of the New York Academy of Sciences|April 21, 1995
Osteopontin production by cultured kidney cellsE M Worcester, J G Kleinman, A M Beshensky
Kidney International|June 1, 1995
Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidneyJ G Kleinman, A Beshensky, E M Worcester, et al.
Nephron|January 1, 1994
Effect of renal transplantation on serum oxalate and urinary oxalate excretionE M Worcester, S K Fellner, Y Nakagawa, et al.
The Journal of Clinical Investigation|June 1, 1986
Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failureE M Worcester, Y Nakagawa, D A Bushinsky, et al.
Pageof 2